Parmax Pharma Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
17.58 Cr.
|
P/BV
|
-27.53
|
Book Value (Rs.)
|
-1.71
|
52 Week High/Low (Rs.)
|
55/25
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
No. of Equity Shares (in Lacs) | 51.01 | 51.01 | 51.01 | 51.01 | 51.01 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 4.45 | 4.45 | 4.45 | 4.45 | 4.45 |
Total Share Capital | 4.45 | 4.45 | 4.45 | 4.45 | 4.45 |
| | | | | |
Reserves and Surplus | -4.38 | 1.40 | 1.51 | 1.37 | 0.61 |
Total Reserves and Surplus | -4.38 | 1.40 | 1.51 | 1.37 | 0.61 |
Total Shareholders Funds | 0.07 | 5.86 | 5.96 | 5.82 | 5.06 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 5.91 | 4.48 | 4.52 | 5.43 | 5.03 |
Deferred Tax Liabilities [Net] | 0.14 | 0.14 | 0.18 | 0.23 | 0.07 |
Total Non-Current Liabilities | 6.05 | 4.62 | 4.70 | 5.66 | 5.11 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Trade Payables | 7.39 | 4.66 | 5.52 | 9.92 | 9.92 |
Other Current Liabilities | 1.60 | 1.50 | 0.86 | 0.49 | 0.24 |
Short Term Provisions | 0.23 | 0.97 | 0.94 | 0.84 | 0.73 |
Total Current Liabilities | 9.21 | 7.14 | 7.32 | 11.25 | 10.89 |
| | | | | |
Total Capital And Liabilities | 15.33 | 17.61 | 17.97 | 22.73 | 21.06 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 9.27 | 9.50 | 10.44 | 10.84 | 9.64 |
Capital Work-In-Progress | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |
Fixed Assets | 9.38 | 9.50 | 10.44 | 10.84 | 9.64 |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.20 | 0.20 |
Long Term Loans And Advances | 0.18 | 0.19 | 0.18 | 0.16 | 0.20 |
Other Non-Current Assets | 0.00 | 0.40 | 0.79 | 1.19 | 1.58 |
Total Non-Current Assets | 9.56 | 10.08 | 11.42 | 12.39 | 11.62 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Inventories | 2.39 | 4.31 | 2.85 | 3.95 | 2.72 |
Trade Receivables | 1.82 | 0.62 | 0.68 | 1.65 | 3.30 |
Cash And Cash Equivalents | 0.05 | 0.41 | 1.05 | 2.55 | 1.77 |
Short Term Loans And Advances | 1.51 | 2.19 | 1.98 | 2.19 | 1.65 |
Total Current Assets | 5.77 | 7.53 | 6.56 | 10.34 | 9.44 |
| | | | | |
Total Assets | 15.33 | 17.61 | 17.97 | 22.73 | 21.06 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.20 | 0.20 |